DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for those affected by Epidermolysis bullosa (EB), today launches a call for Basic Science and Research Grants. This funding opportunity supports high-quality, original research projects focused on inherited forms of EB. DEBRA Research invites applications from researchers committed to driving meaningful scientific and clinical progress that can improve the quality of life for those living with this devastating genetic condition.

A study followed the paths of mothers with perinatal depression. It concluded that high sensitivity to internal and external stimuli can increase the risk of depression, while partner support during pregnancy has a protective effect.

A new study led in part by Mount Sinai researchers has found a compelling link between the composition of the gut microbiome and the risk of cognitive impairment (RCI) in adults, underscoring the complex role that both biology and social determinants—such as food insecurity—play in brain health.

A study of microplastics in U.S. coastal waters found that residents of counties adjacent to the most heavily microplastic-polluted waters had significantly higher rates of Type 2 diabetes, coronary artery disease (plaque-clogged blood vessels feeding the heart) and stroke compared to similar counties located near waters with low levels of microplastic pollution.

The first systematic review on the effects of bipolar medications on the gut microbiome furthers our understanding of the connection between the gut and the brain in patients treated for bipolar disorder. 

By analysing existing datasets, researchers concluded that the health of the gut microbiome may predict a patient’s response to treatment with drugs. 

The results of the study could pave the way for new personalised therapeutic strategies and inspire further studies and clinical trials focused on treatments with the microbiome in mind.